Last updated 2026-07-26
- Raised $18M PIPE, May 2025
- Raised $10M Seed round, Nov 2018
- Raised $350k grant, Jul 2025
Total raised
$28.4M
Last: Grant 2025-08
Stage
Late-stage clinical
Founded
2012
Headcount
24
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Minovia Therapeutics is a clinical-stage biotechnology company developing novel mitochondrial cell therapies to treat people with diseases of mitochondrial dysfunction. The company utilizes its proprietary Mitochondrial Augmentation Technology (MAT) platform, which involves enriching a patient's own hematopoietic stem and progenitor cells (HSPCs) with healthy, functional mitochondria to restore cellular energy production and organ function. Minovia is advancing its lead candidate, MNV-201, through clinical trials for rare pediatric disorders such as Pearson Syndrome and for age-related conditions like myelodysplastic syndrome. The company is also actively developing blood-based mitochondrial biomarkers to better stratify patients and monitor treatment efficacy.
Funding history · 6 rounds · $28.4M total
2025-07
Grant
$350K
2025-05
PIPE
$18.0M
2025-05
Reverse Merger
Undisclosed
2024-12
A Round
Undisclosed
★ 4T Ventures
2021-01
Seed Extension
Undisclosed
★ eit health
2018-11
Seed
$10.0M
Headcount over time
From 7 (2019-08) to 29 (2026-03) · +22 (+314%) · 42 points · source: Finder history + radar grounding
Q&A
- What is Minovia Therapeutics' primary focus?
- Minovia Therapeutics is a clinical-stage biotechnology company that pioneers the use of mitochondrial cell therapy to treat primary genetic and age-related mitochondrial diseases.
- When was Minovia Therapeutics founded and where is it headquartered?
- Minovia Therapeutics was founded in 2012 and is headquartered in Haifa, Israel.
- What is Minovia Therapeutics' proprietary technology platform?
- Minovia Therapeutics utilizes its proprietary Mitochondrial Augmentation Technology (MAT) platform, which enriches a patient's own hematopoietic stem and progenitor cells (HSPCs) with healthy, functional mitochondria.
- What is the current clinical stage of Minovia Therapeutics?
- Minovia Therapeutics is currently in the late-stage clinical phase, advancing its lead candidate, MNV-201.
- Which diseases is Minovia Therapeutics' lead candidate, MNV-201, targeting?
- MNV-201 is being advanced through clinical trials for rare pediatric disorders such as Pearson Syndrome and for age-related conditions like myelodysplastic syndrome.
- What was Minovia Therapeutics' most recent funding event?
- In August 2025, Minovia Therapeutics received a Grant of $350,000 from the Countdown for a Cure Foundation.
- How many employees does Minovia Therapeutics currently have?
- Minovia Therapeutics has an employee count in the 21-50 range.
- Who are the co-founders of Minovia Therapeutics?
- The co-founders of Minovia Therapeutics are Natalie Yivgi-Ohana, Ephraim Aharonson, and Uriel Halavee.
Team · 12
Natalie Yivgi-Ohana
Founder · Co-founder & CEO
Ephraim Aharonson
Founder · Co-founder & Board Member
Uriel Halavee
Founder · Co-founder
Limor Lior
VP People and Culture
Aner Lev
Counsel, Business & Legal Affairs
Shmulik Polak
Director Of Finance
John Cox
Chairman of the Board
Ilan Ganot
Board Member
Shmuel Cabilly
Board Member
Maha Radhakrishnan
Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B
Highlights
Patents
Tags
pediatricsseniorsautoimmune-diseasesbiotechnologycell-therapyrare-diseasespharma-companieschildrenmedical-technologiesmitochondrial-diseasesdrug-discoverylife-sciences
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | minoviatx.com |
|---|---|
| linkedin.com/company/minoviatherapeutics/ |
Identifiers & details
| Legal name | Minovia Therapeutics Ltd. |
|---|---|
| Founded | 2012 |
| Employees (exact) | 24 |
Radar intelligence
Patents
| EPO | 20 |
|---|
Web history (Wayback)
| Domain | minoviatx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514704485 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-12-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 1 — people (1) |
| Registered address | הסדנא 3 טירת כרמל |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-30 | עדכון בעלי תפקידים |